NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children

Jenna K Dick1,2, Jules A Sangala1,2, Venkatramana D Krishna3

  • 1Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN.

Insights

Multisystem inflammatory syndrome in children (MIS-C) involves immune cell dysfunction. Researchers found that while monocytes were hyperfunctional, Natural Killer (NK) cells showed impaired killing and cytokine production, potentially impacting viral clearance.

Area of Science:

  • Immunology
  • Pediatric Infectious Diseases
  • Cellular Biology

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection.
  • MIS-C involves multiorgan inflammation and aberrant immune responses.
  • Understanding cellular immune dysfunction in MIS-C is crucial for effective treatment.

Purpose of the Study:

  • To investigate cellular immune responses, specifically cell-mediated antibody (Ab) functions, in children with MIS-C.
  • To explore the role of dysfunctional cellular immunity in delayed viral product clearance.
  • To identify potential therapeutic strategies targeting immune cell defects in MIS-C.

Main Methods:

  • Ex vivo testing of cellular functions, including phagocytosis, cytokine production, and cytotoxicity.
  • Analysis of Natural Killer (NK) cell exhaustion markers and correlation with Interleukin-6 (IL-6) levels.
  • In vitro experiments using cellular engagers targeting CD16 and SARS-CoV-2 proteins to assess NK cell function rescue.

Main Results:

  • Monocytes in MIS-C patients exhibited hyperfunctional phagocytosis and cytokine production.
  • NK cells displayed hypofunctional killing and cytokine production, linked to an exhaustion signature and elevated IL-6.
  • Cellular engagers demonstrated potential to restore NK cell function in vitro.

Conclusions:

  • Dysregulation in Ab-mediated cellular responses involving myeloid and NK cells contributes to MIS-C immune pathology.
  • Impaired NK cell function may hinder viral product clearance in MIS-C.
  • Targeting NK cell dysfunction presents a potential therapeutic avenue for MIS-C.